Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Haase

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
Cell Stem Cell|July 10, 2026
Generation of spermatogonia from human and non-human primate pluripotent stem cellsEoin C Whelan, Mingyue Guo, Ryo Yokomizo, et al.
Nucleic Acids Research|May 31, 2022
Functional editing of endogenous genes through rapid selection of cell pools (Rapid generation of endogenously tagged genes in Drosophila ovarian somatic sheath cells)Qingcai Meng, Daniel Stoyko, Celine Marlin Andrews, et al.
Nature Communications|February 21, 2019
Decoding the 5' nucleotide bias of PIWI-interacting RNAsChad B Stein, Pavol Genzor, Sanga Mitra, et al.
Nanotechnology|July 27, 2010
Delivery of carboplatin by carbon-based nanocontainers mediates increased cancer cell deathM Arlt, D Haase, S Hampel, et al.
British Journal of Haematology|December 24, 1997
The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis. German AML Cooperative Study GroupC Schoch, D Haase, C Fonatsch, et al.
Frontiers in Cardiovascular Medicine|April 7, 2022
Remote Design of a Smartphone and Wearable Detected Atrial Arrhythmia in Older Adults Case Finding Study: Smart in OAC - AFNET 9Larissa Fabritz, D Connolly, E Czarnecki, et al.
Journal of Cancer Research and Clinical Oncology|June 11, 1999
Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside/mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromesW Verbeek, B Wörmann, P Koch, et al.
Cell Reports|August 17, 2022
Transcriptomics, regulatory syntax, and enhancer identification in mesoderm-induced ESCs at single-cell resolutionMamduh Khateb, Jelena Perovanovic, Kyung Dae Ko, et al.
Annals of Hematology|October 18, 2012
Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overloadF Nolte, B Höchsmann, A Giagounidis, et al.
Annals of Hematology|June 9, 2025
Refinement of intermediate-risk Karyotypes according to the IPSS-R in patients with myelodysplastic neoplasms (MDS)K Nachtkamp, F Schulz, A Kasprzak, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
Cell Stem Cell|July 10, 2026
Generation of spermatogonia from human and non-human primate pluripotent stem cellsEoin C Whelan, Mingyue Guo, Ryo Yokomizo, et al.
Nucleic Acids Research|May 31, 2022
Functional editing of endogenous genes through rapid selection of cell pools (Rapid generation of endogenously tagged genes in Drosophila ovarian somatic sheath cells)Qingcai Meng, Daniel Stoyko, Celine Marlin Andrews, et al.
Nature Communications|February 21, 2019
Decoding the 5' nucleotide bias of PIWI-interacting RNAsChad B Stein, Pavol Genzor, Sanga Mitra, et al.
Nanotechnology|July 27, 2010
Delivery of carboplatin by carbon-based nanocontainers mediates increased cancer cell deathM Arlt, D Haase, S Hampel, et al.
British Journal of Haematology|December 24, 1997
The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis. German AML Cooperative Study GroupC Schoch, D Haase, C Fonatsch, et al.
Frontiers in Cardiovascular Medicine|April 7, 2022
Remote Design of a Smartphone and Wearable Detected Atrial Arrhythmia in Older Adults Case Finding Study: Smart in OAC - AFNET 9Larissa Fabritz, D Connolly, E Czarnecki, et al.
Journal of Cancer Research and Clinical Oncology|June 11, 1999
Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside/mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromesW Verbeek, B Wörmann, P Koch, et al.
Cell Reports|August 17, 2022
Transcriptomics, regulatory syntax, and enhancer identification in mesoderm-induced ESCs at single-cell resolutionMamduh Khateb, Jelena Perovanovic, Kyung Dae Ko, et al.
Annals of Hematology|October 18, 2012
Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overloadF Nolte, B Höchsmann, A Giagounidis, et al.
Annals of Hematology|June 9, 2025
Refinement of intermediate-risk Karyotypes according to the IPSS-R in patients with myelodysplastic neoplasms (MDS)K Nachtkamp, F Schulz, A Kasprzak, et al.
Pageof 15